Lykos Therapeutics

📍 San Jose, United States🗓 Founded 2014👥 70 employees💰 Last funded Jan 2025
Biotechnology Research🌐 lykospbc.com
Website LinkedIn
At Lykos Therapeutics, our mission is to transform mental healthcare. We’re applying decades of evidence-based research to develop investigational psychedelics to catalyze therapeutic approaches for mental health conditions. We are relentlessly exploring and reimagining novel approaches to address unmet needs in the mental healthcare space, with an initial focus on PTSD. As a Public Benefit Company, we are focused on delivering positive impact on our people, communities and society. To learn more, visit us at www.lykospbc.com.
5
Total investors
0
Early stage
0
Mid stage
4
Late stage
2014
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2022–2025 · investors recorded per year
202222023220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Lykos Therapeutics?
Lykos Therapeutics has 5 investors on record on gritt.io and 4 late-stage investors.
When did Lykos Therapeutics last raise funding?
The most recent investment in Lykos Therapeutics recorded on gritt.io was in January 2025.
When was Lykos Therapeutics founded?
Lykos Therapeutics was founded in 2014.
What industry is Lykos Therapeutics in?
Lykos Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lykos Therapeutics based?
Lykos Therapeutics is headquartered in San Jose, United States.